Ventyx Biosciences Inc.

29/07/2024 | Press release | Distributed by Public on 29/07/2024 12:17

Ventyx Biosciences Announces Results from the Phase 2 Trial of VTX958 in Participants with Moderately to Severely Active Crohn’s Disease